Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
Citi
Cantor Fitzgerald
Daiichi Sankyo
Cerilliant
AstraZeneca
Teva
Boehringer Ingelheim

Generated: May 24, 2018

DrugPatentWatch Database Preview

KHEDEZLA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Khedezla, and what generic alternatives are available?

Khedezla is a drug marketed by Osmotica Pharm Corp and is included in one NDA.

The generic ingredient in KHEDEZLA is desvenlafaxine. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the desvenlafaxine profile page.
Drug patent expirations by year for KHEDEZLA
Synonyms for KHEDEZLA
(RS)-1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol
(S)-Desmethyl Venlafaxine D6
1-[1-(4-hydroxyphenyl)-2-dimethylaminoethyl]cyclohexanol
1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol
1-[2-dimethylamino-1-(4-hydroxyphenyl)ethyl]cyclohexanol
4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
4-[1-(1-hydroxycyclohexyl)-2-(dimethylamino)ethyl]phenol
4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol #
4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol
4-[2-Dimethyamino-1-(1-hydroxycyclohexyl)ethyl]phenol
4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol
413D628
4CH-007182
93413-62-8
A844583
AB0031560
AB01563022_01
AC1L2NUV
ACMC-20ek0k
AK-72949
AKOS015896311
AT-19352
AX8123273
BDBM86748
BR-72949
CAS_386750-22-7
CHEBI:83527
CHEMBL1118
CS-2818
CTK8E8385
d,l-O-Desmethylvenlafaxine
D07793
D0O3FG
DB06700
Desvenlafaxine
Desvenlafaxine (INN)
Desvenlafaxine [INN:BAN]
desvenlafaxine(o-desnethylvenfaxine)
dl-o-desmethylvenlafaxin
DS-1282
DVS 233
EC 700-516-2
FT-0654519
GTPL7158
HMS3652K16
HSDB 7993
HY-B0602
I06-2078
J10126
KB-33580
KS-00000FZO
KYYIDSXMWOZKMP-UHFFFAOYSA-N
LS-178212
MFCD00871934
MLS006010042
MolPort-003-846-411
NSC_6918664
O-desmethyl venlafaxine
o-desmethyl venlafaxine-d10
O-desmethyl-venlafaxine
O-Desmethylvenlafaxine
O-DESMETHYLVENLAFAXINE (ODV)
O-Desmethylvenlafaxine 0.1 mg/ml in Methanol
O-Desmethylvenlafaxine solution, 1.0 mg/mL in methanol, certified reference material
O-Desmethylvenlafaxine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material
O-Desmethylvenlafaxine, analytical standard
ODV
OR009033
OR219991
PDSP1_001804
PDSP2_001787
Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-
Phenol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]-
Pristiq
S-2830
s4113
SC-82264
SCHEMBL34864
SMR004701214
ST2410953
ST51051296
TR-029259
WY 45,233
WY-45,233
Wy-45233
X4688

US Patents and Regulatory Information for KHEDEZLA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Osmotica Pharm Corp KHEDEZLA desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204683-001 Jul 10, 2013 BC RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Osmotica Pharm Corp KHEDEZLA desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204683-002 Jul 10, 2013 BC RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Covington
Mallinckrodt
Healthtrust
Merck
AstraZeneca
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.